Close
Smartlab Europe
Achema middle east

Drug Research

EMA Follows FDA In Restricting Immune-Regulating Medicines

On October 28th, an advisory board to the European Medicines Agency advised restricting the use of a class of medications for inflammatory diseases due to a known association with side effects like cancer and heart attacks. The group recommended limiting...

China Releases The First COVID Vaccination That Is Inhaled

A new type of COVID-19 vaccination that is provided via inhalation rather than injection was this week introduced in Shanghai, the commercial city of China, in what is thought to be a first for the world. In September, Chinese authorities...

FDA Under Pressure To Alter Accelerated Approval Program

The necessity to update and alter the FDA's now-contentious rapid approval strategy is highlighted by the protracted, complicated FDA process to discontinue commercialization of medications that do not demonstrate safety and efficacy in mandated post-approval confirmatory studies. Over the...

Less Prostate Cancer Testing Leads To More Advanced Tumours

According to data from the U.S. Department of Veterans Affairs (VA), a reduction in prostate cancer screening has been associated with a subsequent rise in advanced malignancies. These findings may prompt a review of the country's current testing recommendations....

Scientists At ICR Research Cancer Response To New Treatments

Researchers discovered that by turning off the function of two genes, stomach tumours can become resistant to ATR inhibitors. As a result, genetic screening tests may one day be used to identify patients with cancers that are most likely...

CDC Suggests Pairing Novavax COVID Shot With Pfizer, Moderna

The Centers for Disease Control and Prevention on October 19 advised adults in the United States to take Covid boosters from Novavax, even those who had received their primary round of doses from Pfizer, Moderna, or Johnson & Johnson. Adults 18...

FDA To Fund $38 Million To Fuel 4-Year Rare Disease Research

A total of $38 million has been granted by the US Food and Drug Administration (FDA) in the form of 19 new grants and two new contracts to support the forthcoming four years of clinical trial trials and regulatory...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »